Presenting Monogenic Heart Failure Disease Modeling in Kyoto
Feb. 17, 2023
Courtesy ofInvivoSciences, Inc. (IVS)
https://www.termis.org/wc2018/
On September 7th, CSO speaks about monogenic disease modeling using NuHeart™ technology during TERM for heart, blood vessel & lung session.
99-O-5: Personalized micro-3D human heart
tissues for orphan drug development
Tetsuro Wakatsuki,Neil Daily,Pinar Kemanli,
Michael Greenberg,Jennifer Strande
InvivoSciences, Inc. Madison Wisconsin, USA, Washington University, St. Louis, Medical College of Wisconsin.
Stay in the loop!
Select your areas of interest to receive industry updates.